Upregulation of TRIB2 by Wnt/β-catenin activation in BRAFV600E papillary thyroid carcinoma cells confers resistance to BRAF inhibitor vemurafenib
Keyword(s):
2019 ◽
Vol 234
(10)
◽
pp. 18382-18391
◽
Keyword(s):
2020 ◽